<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

Q318 CAS Ortho Market Recap: Robotics Contribute to Above Market Growth

Posted by Elise Wolf on 1/11/19 11:55 AM

Robotics Contributing to Above Market Growth Through Implant Pull-Through

Robotics continued to be a hot topic in orthopedics in Q318 with some companies and surgeons projecting that robotics will become standard-of-care in orthopedic procedures in the next 3-5 years...

Among the many interesting topics covered in SmartTRAK's Q318 CAS Ortho Market Recap are:

Read More

Topics: Computer Assisted Surgery - Ortho, Q318 Market Recaps

Q318 CAS Spine Market Recap: Medtronic Leads Market in Robotics

Posted by Elise Wolf on 1/10/19 9:30 AM

Spine robotics was a hot topic throughout Q318, culminating at the NASS meeting in September.

SmartTRAK reports that with increasing adoption of spine robotic systems and potential expanded indications beyond pedicle screw placement on the horizon, market leader Medtronic believes that robotics will expand from ~5% of procedures in the US today to reach up to...

Among the many interesting topics covered in SmartTRAK's Q318 CAS Spine Market Recap are:

Read More

Topics: Q318 Market Recaps

Q318 Extremities Market Recap: Increased Pricing Pressure

Posted by Natasha Weeks on 1/9/19 9:30 AM

Extremities Fixation decelerates as shoulder replacements remain strong

 Q318 WW Extremities Market growth declined sequentially to +3.7%, compared to +6.2% growth in Q2. Steeper growth slowdowns in the fixation market segments – Upper Extremities Fixation at +1.8% and Foot & Ankle Fixation at +1.4% - were due in part to...
 

Among the many topics covered in SmartTRAK's Q318 Extremities  Market Recap are:

Read More

Topics: Orthopedics-Extremities, Q318 Market Recaps

Q318 Trauma Market Recap: Pricing Pressure Impacts Growth

Posted by Natasha Weeks on 1/8/19 2:31 PM

Tough comps, supply disruption and the ever-present pricing pressure impacts growth

SmartTRAK reports that the WW Trauma Market experienced a downturn in Q3, posting only +1.1% (reported) growth. The US Market was up +2.0% YoY, but is down sequentially compared to last quarter’s +5.0% gains...

Among the many topics covered in SmartTRAK's Q318 Trauma Market Recap are:

Read More

Topics: Q318 Market Recaps, Orthopedics-Trauma

Q318 Market Recap: US Surgical Matrices

Posted by Doug Devens on 1/8/19 9:30 AM

The US Surgical Matrices Market continued to advance in Q318, up +10.3% YoY, fueled by continued rapid adoption of allograft breast matrices and the resurgence of synthetic hernia matrices.

According to BioMedGPS’  SmartTRAK Financial Dashboard, in Q318, the US Surgical Matrices Market grew +10.3% YoY. The allograft breast matrices and biosynthetic hernia matrices segments outpaced overall market growth, as both posted...

Among the many interesting topics covered in the Q318 US Surgical Matrices Market Recap are:

Read More

Topics: Surgical Matrices, Q318 Market Recaps

Q318 Infection Prevention: Vascular Access Adjunct Products Market Recap

Posted by Susan Paquette on 1/4/19 9:30 AM

Growth continues for another quarter as market leaders gain more share.

For Q318, according to BioMedGPS’ SmartTRAK Financial Dashboard, the US Infection Prevention - Vascular Access Adjunct Products market grew +4.3% YoY.

Among the many topics covered in the Q318 Infection Prevention Market Recap are:

Read More

Topics: Q318 Market Recaps, Wound Care-Infection Prevention

Q318 US Hemostats and Sealants Market Recap

Posted by Doug Devens on 1/3/19 12:00 PM

The US market for Hemostats and Sealants accelerated substantially in Q318 vs Q218

As reported in SmartTRAK’s Financial Dashboard, every manufacturer in the Hemostats and Sealants market, with the exception of Pfizer, saw revenue growth in Q318. Leading the way were Baxter, with its integration of the Mallinckrodt portfolio, as well as Ethicon and Integra, while Pfizer posted...

Among the many topics covered in the Q318 US Hemostats and Sealants Market Recap are:

Read More

Topics: Q318 Market Recaps, Biosurgery-Hemostats and Sealants

Q318 Spine Market Recap: Spine Hardware Market is Stabilizing

Posted by Julianne Burns on 1/2/19 12:02 PM

The Spine hardware market appears to be stabilizing.

SmartTRAK reports that results from a recent Leerink MEDACorp survey suggest that the US Spine market may be turning the corner, with hospital administrators reporting slightly improved case volume growth of 0.9% for Q318 vs 0.7% for Q2. This is consistent with Leerink’s intra-quarter checks and conversations at the North American Spine Society (NASS) 2018 Annual Meeting that the market...

Among the many topics covered in the Q318 Spine Market Recap are:

Read More

Topics: Orthopedics-Spine, Q318 Market Recaps

Q318 OrthoBio Market Recap: Acquisitions and Partnerships Rule

Posted by Kim French on 12/14/18 2:28 PM

Acquisitions and Partnerships are Highpoints in Q318

SmartTRAK reports that the US OrthoBio Market (comprised of Bone Replacement, Cartilage, Soft Tissue and Meniscus) is growing at 4.1% YTD. For Q318, there were no surprises and the segment reached...

Among the many topics covered in the Q318 OrthoBio Market Recap are:

Read More

Topics: OrthoBio, Q318 Market Recaps

Q318 Advanced Wound Care Market Recap: All Segments Showing Softness

Posted by Susan Paquette on 12/13/18 1:54 PM

All segments showing softness, lowest quarterly growth rate since 2015

For Q318, according to BioMedGPS’ SmartTRAK Financial Dashboard, WW Advanced Wound Care (AWC) revenues for Advanced Dressings, External Devices and Biologics was up +3.0% YoY, with Acelity, also known as KCI, maintaining its leadership position with estimated Q318 revenues of...

Read More

Topics: Advanced Wound Care, Q318 Market Recaps

Subscribe to News and Analysis Blog Weekly Emails

SmartTRAK is the leading source of competitive intelligence used by the top ten global orthopedic and wound care companies. 

Recent Posts